 |
United States IVD Market (By Application Segments, Products, Region, End Users) Size, Share, Major Deals & Company Analysis - Forecast to 2025
United States In Vitro Diagnostics (IVD) market is expected to reach US$ 33.7 Billion by 2025. United States represents the largest IVD market across the world. With an aging population, technological advances and advent of point of care diagnostics, United States IVD market is slated to show substantial growth in the future. The increase in the US in vitro diagnostics market is majorly driven by high prevalence of chronic diseases, such as heart diseases, cancer, asthma, and diabetes. It is estimated that these diseases are responsible for the majority of deaths in the United States, killing more than 1.7 million US citizens annually. All of these conditions can be diagnosed and monitored using IVD products. Thus, IVDs have proved to be beneficial in managing these chronic conditions. However, some of the factors limiting the growth of the market are a lack of proper reimbursement policies and lack of skilled lab technicians.
United States In-Vitro Diagnostics Market - Application Segments Analysis
• On the basis of segment, the POC-OTC diabetes diagnostics segment accounted for highest share of the United States in-vitro diagnostics market, followed by the POC - Professional segment.
• Immunoassays have become one of the primary and indispensable tools in the diagnosis and monitoring of all diseases and medical conditions.
• The non-infectious immunoassays contribute significantly to the United States IVD market.
• It is anticipated that the molecular microbiology segment will account for nearly 10% share of the United States IVD market by 2025.
• The Clinical chemistry segment contributed around 8% to the United States IVD market in 2018.
• Histology and Hematology segments are competing closely with each other to grab maximum share of the pie.
• Urinalysis captures least share of the United States in vitro diagnostics market.
United States In-Vitro Diagnostics Market - Products Analysis
• Instruments is the leading product segment of the United States In-Vitro Diagnostics (IVD) market, followed by the reagents segment.
• The software segment holds close to 15% share of the United States IVD market in 2018, due to growing preference for reliable and efficient diagnostic software.
• Services segment captured least share of the United States in vitro diagnostics market, but it is likely to show impressive growth throughout the forecast period.
United States In-Vitro Diagnostics Market - Regional Analysis
• The largest share of the US in vitro diagnostics market is currently in the South of the country with the West being second.
• Midwest region accounts for nearly 22% share of the total US IVD market in 2018, as an increasing number of accredited laboratories opening in that area.
• The North East region accounted for least share of the total US IVD market.
United States In-Vitro Diagnostics Market - End Users Analysis
• Hospitals captures highest share of the United States IVD market, owing to the large volume of diagnostic tests carried out in hospitals.
• An increasing number of independent accredited laboratories are opening all over the country, thus driving the market for laboratories segment.
• The other end users (Self Testing, Retail Clinics, Physician Office Labs, Others) segment contributed nearly a quarter to the United States IVD market.
iGATE RESEARCH report titled “United States IVD Market (By Application Segments, Products, Region, End Users) Size, Share, Major Deals & Company Analysis - Forecast to 2025” provides a comprehensive assessment of the fast-evolving, high-growth United States IVD Market.
This 201 Page report with 73 Figures and 8 Tables has been analyzed from 9 View Points:
1) United States IVD Market and Forecast (2013 - 2025)
2) United States IVD Market Share and Forecast (2013 - 2025)
3) United States IVD Market & Forecast - By Application Segments (2013 - 2025)
4) United States IVD Market & Forecast - By Products (2013 - 2025)
5) United States IVD Market & Forecast - By Region (2013 - 2025)
6) United States IVD Market & Forecast - By End Users (2013 - 2025)
7) United States IVD Market & Forecast - Company Profiles (2013 - 2025)
8) United States IVD Market - Major Deals
9) United States IVD Industry Drivers & Challenges
United States In-Vitro Diagnostics Market - By Application Segments
1. Clinical Chemistry
2. Microbiology -ID/AST
3. Microbiology - Molecular
4. POC - Professional
5. POC - OTC Diabetes
6. POC - Others
7. Immunoassay - Infectious
8. Immunoassay - Others
9. Urinalysis
10. Molecular - Non-Infectious
11. Coagulation
12. Histology
13. Hematology
14. Blood Testing and Typing
15. Flow Cytometry
United States In-Vitro Diagnostics Market - By Products
• Instruments
• Reagents
• Software
• Services
United States In-Vitro Diagnostics Market - By Region
• South
• West
• Midwest
• North East
United States In-Vitro Diagnostics Market - By End Users
• Hospitals
• Laboratories
• Others
United States In-Vitro Diagnostics Market - Company Profiles
1. Roche Diagnostic
2. Abbott Laboratories
3. Siemens Healthineers
4. Danaher Corporation
5. Thermo Fisher Scientific
6. Sysmex Corporation
7. Biomerieux
8. Bio-Rad Laboratories, Inc
9. Becton Dickinson and Company
Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=166
Contact US
iGATE Research PVT LTD
Ravi Sinha
Sales Manager
Marketing and Sales Divison
Email: ravi.sinha@igateresearch.com
Contact: +91-858-684-0791, +91-821-092-7469 (INDIA)
Web: www.igateresearch.com
Контактное лицо: iGATE Research
Компания: iGATE Research
Добавлен: 20:04, 14.10.2019
Количество просмотров: 537
Страна: Россия
| RedLab вошла в топ-4 Рейтинга Рунета – 2026, RedLab, 21:55, 13.10.2026, Россия320 |
| Компания RedLab заняла 4-е место в основном рейтинге «Аутстаффинг разработчиков» по версии Рейтинга Рунета – 2026, поднявшись сразу на восемь позиций по сравнению с прошлым годом. |
| Безопасность как драйвер, ИИ как ядро: куда идет российский рынок IBP, Круги Громова, 21:54, 13.10.2026, Россия327 |
| Гибридные модели вместо крайностей, ИИ в ядре продукта, безопасность как драйвер выбора, размывание границ между классами решений и зрелость данных как главный барьер – эти пять трендов сегодня определяют российский рынок решений для интегрированного бизнес-планирования (IBP), систем планирования цепочек поставок (SCP) и финансового планирования (FP&A). |
| Офис компании «Первый Бит» «Шоссе Энтузиастов» получил статус «Центр ERP», Первый Бит, 21:48, 13.10.2026, Россия115 |  |
| Специалисты офиса помогают компаниям автоматизировать ключевые процессы: управление производством, закупками, запасами, продажами, финансами, персоналом и другими направлениями деятельности. Получение статуса «Центр ERP» стало результатом развития компетенций команды, накопленного проектного опыта и соответствия высоким требованиям фирмы «1С». |
| МИФИ при поддержке Смарт Текнолоджис покоряют «Битву роботов», Смарт Текнолоджис, 21:44, 13.10.2026, Россия78 |
| Инженерная команда «МИФИческие гонщики» НИЯУ МИФИ, выступающая при поддержке компании «Смарт Текнолоджис», вышла в финальные состязания международного чемпионата «Битва роботов — 2026», одержав победу в отборочном этапе. Финал состоится 31 октября в Казани. Чемпионат, объединивший 144 команды из 10 стран, проводится в рамках ИТ-форума «Цифровые решения» и Kazan Digital Week. |
| «1С-Рарус» представил отраслевые решения на партнерском семинаре 1С, 1С-Рарус, 21:42, 13.10.2026, Россия57 |
| «1С‑Рарус» провел отраслевой день в рамках традиционного осеннего партнерского семинара фирмы «1С». К трансляции 15 докладов подключились 230 слушателей. Эксперты «1С-Рарус» показали, как ИИ помогает решать повседневные задачи бизнеса. Разобрали, какие процессы и учетные системы нужно изменить для работы с ЭПД и маркированными товарами. |
|
|
